Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $11.0 million.

  • Camp4 Therapeutics' Total Non-Current Liabilities fell 3954.92% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 3954.92%. This contributed to the annual value of $15.2 million for FY2024, which is 826.53% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Total Non-Current Liabilities stood at $11.0 million for Q3 2025, which was down 3954.92% from $11.3 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Total Non-Current Liabilities registered a high of $18.2 million during Q3 2024, and its lowest value of $11.0 million during Q3 2025.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $13.2 million (2024), whereas its average is $13.9 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 826.53% in 2024, then plummeted by 3954.92% in 2025.
  • Camp4 Therapeutics' Total Non-Current Liabilities (Quarter) stood at $16.5 million in 2023, then decreased by 8.27% to $15.2 million in 2024, then fell by 27.47% to $11.0 million in 2025.
  • Its last three reported values are $11.0 million in Q3 2025, $11.3 million for Q2 2025, and $11.2 million during Q1 2025.